Gary S. Hogge Lineage Cell Therapeutics, Inc. (LCTX) insider trading activity

Gary S. Hogge is SVP,Clinical & Medical Affairs of Lineage Cell Therapeutics, Inc.. Currently has a direct ownership of 7,710 shares of LCTX, which is worth approximately $6,322. The most recent transaction as insider was on Feb 11, 2023, when has been sold 5,310 shares (Common Shares, no par value) at a price of $1.35 per share, resulting in proceeds of $7,168. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.71K

0% 3M change

0% 12M change

Total Value Held $6,322

Gary S. Hogge Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 11 2023	SELL Payment of exercise price or tax liability	$7,168 $1.35 p/Share	5,310 Reduced 40.78%	7,710 Common Shares, no par ...
Feb 11 2023	BUY Exercise of conversion of derivative security	-	13,020 Added 50.0%	13,020 Common Shares, no par ...
Dec 29 2021	SELL Open market or private sale	$93,107 $2.47 p/Share	37,695 Reduced 100.0%	0 Common Shares, no par ...
Dec 29 2021	BUY Exercise of conversion of derivative security	$6,382 $0.69 p/Share	9,250 Added 19.7%	37,695 Common Shares, no par ...
Dec 28 2021	SELL Open market or private sale	$1,228,891 $2.45 p/Share	501,588 Reduced 94.63%	28,445 Common Shares, no par ...
Dec 28 2021	BUY Exercise of conversion of derivative security	$657,080 $1.31 p/Share	501,588 Added 48.62%	530,033 Common Shares, no par ...

GSH

Gary S. Hogge

SVP,Clinical & Medical Affairs

Carlsbad, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LCTX shares.

Notify only if

Value

Insider Trading

Get notified when an Lineage Cell Therapeutics, Inc. insider buys or sells LCTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Lineage Cell Therapeutics, Inc.

Track Activities on LCTX

Account